These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 861130)

  • 1. Evaluation of once daily sotalol administration in man.
    McDewitt DG; Shanks RG
    Br J Clin Pharmacol; 1977 Apr; 4(2):153-6. PubMed ID: 861130
    [No Abstract]   [Full Text] [Related]  

  • 2. Observations on the efficacy and pharmacokinetics of sotalol after oral administration.
    Brown HC; Carruthers SG; Kelly JG; McDevitt DG; Shanks RG
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):367-72. PubMed ID: 971701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of once and twice daily sotalol in exercise-induced angina pectoris.
    Wilhelmsson C; Vedin A; Ulvenstam G; Aberg A; Descamps R; Thomis JA
    Eur J Clin Pharmacol; 1982; 21(6):461-5. PubMed ID: 7075651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effects of practolol and sotalol.
    Sundquist H; Anttila M; Arstila M
    Clin Pharmacol Ther; 1974 Sep; 16(3):465-72. PubMed ID: 4606232
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the activity and plasma levels of oxprenolol, slow release oxprenolol, long acting propranolol and sotalol.
    Leahey WJ; Neill JD; Varma MP; Shanks RG
    Eur J Clin Pharmacol; 1980 Jun; 17(6):419-24. PubMed ID: 7398733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjects.
    Barbey JT; Sale ME; Woosley RL; Shi J; Melikian AP; Hinderling PH
    Clin Pharmacol Ther; 1999 Jul; 66(1):91-9. PubMed ID: 10430114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the cardiovascular effects of (+)-sotalol and (+/-)-sotalol following intravenous administration in normal volunteers.
    Johnston GD; Finch MB; McNeill JA; Shanks RG
    Br J Clin Pharmacol; 1985 Nov; 20(5):507-10. PubMed ID: 4074623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human pharmacokinetics of sotalol.
    Anttila M; Arstila M; Pfeffer M; Tikkanen R; Vallinkoski V; Sundquist H
    Acta Pharmacol Toxicol (Copenh); 1976 Jul; 39(1):118-28. PubMed ID: 988964
    [No Abstract]   [Full Text] [Related]  

  • 9. QT prolongation and serum sotalol concentration are highly correlated following intravenous and oral sotalol.
    Somberg JC; Preston RA; Ranade V; Molnar J
    Cardiology; 2010; 116(3):219-25. PubMed ID: 20693799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of hypertension with single daily doses of sotalol hydrochloride.
    Gabriel R
    Curr Med Res Opin; 1976-1977; 4(10):739-42. PubMed ID: 1052165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma level and action of sotalol-HCL on the ECG interval after parenteral administration in healthy subjects].
    Rehm KD; Schnelle K; Dyde CJ; Blümner E; Arendts W
    Arzneimittelforschung; 1987 Sep; 37(9):1058-62. PubMed ID: 3435602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of the -adrenergic blocker sotalol in dogs.
    Schnelle K; Garrett ER
    J Pharm Sci; 1973 Mar; 62(3):362-75. PubMed ID: 4144183
    [No Abstract]   [Full Text] [Related]  

  • 13. Sotalol in the treatment of angina pectoris. A double-blind cross-over study.
    Kentala E; Pyörälä K; Frick MH
    Ann Clin Res; 1974 Oct; 6(5):253-7. PubMed ID: 4614692
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG; Brown HC; Carruthers SG; Shanks RG
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative beta-adrenoceptor blocking effects and pharmacokinetics of sotalol and propranolol in healthy volunteers].
    Richer C; Maury M; Poirier JM; Duhaze P; Giudicelli JF
    Therapie; 1982; 37(3):259-67. PubMed ID: 6753226
    [No Abstract]   [Full Text] [Related]  

  • 16. Duration of action of beta-blocking drugs.
    Carruthers SG; Kelly JG; McDevitt DG; Shanks RG; Walsh MJ
    Br Med J; 1973 Apr; 2(5859):177. PubMed ID: 4144672
    [No Abstract]   [Full Text] [Related]  

  • 17. Blunting of exercise-induced tachycardia and renin release 24 hours after a single dose of sotalol.
    Kiowski W; Bühler FR; Van Brummelen P; Küng M
    J Clin Pharmacol; 1979; 19(8-9 Pt 2):513-5. PubMed ID: 489769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics in young normal and elderly hypertensive subjects: a study using sotalol as a model drug.
    Ishizaki T; Hirayama H; Tawara K; Nakaya H; Sato M; Sato K
    J Pharmacol Exp Ther; 1980 Jan; 212(1):173-81. PubMed ID: 6101341
    [No Abstract]   [Full Text] [Related]  

  • 19. Once daily sotalol in the treatment of hypertension.
    Shaw HL
    J R Coll Gen Pract; 1977 Dec; 27(185):742-5. PubMed ID: 616864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels and half-life of sotalol in chronic renal failure.
    Sundquist HK; Anttila M; Forsström J; Kasanen A
    Ann Clin Res; 1975 Dec; 7(6):442-6. PubMed ID: 1211858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.